Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

about

Molecular Tumor Boards: Current Practice and Future Needs.

P2860

Q42697732-0A56C621-3219-4864-BE0D-10F781188867

P2860

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

Item

http://www.wikidata.org/entity/Q36307517

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Are life-saving anticancer dru ...... he European Union and the USA.

@ast

Are life-saving anticancer dru ...... he European Union and the USA.

@en

type

Item

label

Are life-saving anticancer dru ...... he European Union and the USA.

@ast

Are life-saving anticancer dru ...... he European Union and the USA.

@en

prefLabel

Are life-saving anticancer dru ...... he European Union and the USA.

@ast

Are life-saving anticancer dru ...... he European Union and the USA.

@en

P1476

Are life-saving anticancer dru ...... he European Union and the USA.

@en

P2093

Christelle Senterre

http://www.w3.org/2001/XMLSchema#string

Dimitrios Zardavas

http://www.w3.org/2001/XMLSchema#string

Martine Piccart

http://www.w3.org/2001/XMLSchema#string

Razvan Popescu

http://www.w3.org/2001/XMLSchema#string

P2860

The weight of nations: an estimation of adult human biomass

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Molecular portraits of human breast tumours

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

P304

e0172351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0172351

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Evandro de Azambuja

Felipe Ades

P577

2017-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28291814

http://www.w3.org/2001/XMLSchema#string

P932

5349665

http://www.w3.org/2001/XMLSchema#string

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

about

P2860

P2860

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932